Cargando…

Comparing Cost-Effectiveness Results for a Vaccine Across Different Countries Worldwide: What Can We Learn?

INTRODUCTION: Cost-effectiveness analysis (CEA) using country-specific thresholds tied to gross domestic product (GDP) might not be appropriate in countries with low healthcare investment and a high disease burden as a consequence. METHODS: Using data from previously published CEA of rotavirus vacci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Standaert, Baudouin, Ethgen, Olivier, Emerson, Rachel, Postma, Maarten, Mauskopf, Josephine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209096/ https://www.ncbi.nlm.nih.gov/pubmed/25331617 http://dx.doi.org/10.1007/s12325-014-0160-6

Ejemplares similares

Discounting health gain: a different view
por: Standaert, Baudouin, et al.
Publicado: (2023)

3. How comprehensive can we be in the economic assessment of vaccines?
por: Standaert, Baudouin, et al.
Publicado: (2017)

Budget constraint and vaccine dosing: a mathematical modelling exercise
por: Standaert, Baudouin A, et al.
Publicado: (2014)

How much money is spent on vaccines across Western European countries?
por: Ethgen, Olivier, et al.
Publicado: (2016)

The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country
por: Standaert, Baudouin
Publicado: (2023)

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world
por: Postma, Maarten J, et al.
Publicado: (2011)

Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?
por: Mauskopf, Josephine, et al.
Publicado: (2021)

PHYSICAL HEALTH CONDITIONS IN PERSONS WITH SPINAL CORD INJURY ACROSS 21 COUNTRIES WORLDWIDE
por: STRØM, Vegard, et al.
Publicado: (2022)

Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe
por: Standaert, Baudouin, et al.
Publicado: (2022)

Can we reduce worldwide neonatal mortality?
por: Parmigiani, Stefano, et al.
Publicado: (2022)

Informing decision makers seeking to improve vaccination programs: case-study Serbia
por: Sauboin, Christophe, et al.
Publicado: (2021)

Can we rely on COVID-19 data? An assessment of data from over 200 countries worldwide
por: Farhadi, Noah
Publicado: (2021)

Solving the worldwide emergency department crowding problem – what can we learn from an Israeli ED?
por: Pines, Jesse M., et al.
Publicado: (2015)

Application and Surgical Technique of ACL Reconstruction Using Worldwide Registry Datasets: What Can We Extract?
por: Wittig, Ulrike, et al.
Publicado: (2021)

Impact of Rotavirus Vaccination on Hospitalisations in Belgium: Comparing Model Predictions with Observed Data
por: Standaert, Baudouin, et al.
Publicado: (2013)

Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs
por: Standaert, Baudouin, et al.
Publicado: (2020)

Viral Hepatitis Induces Hepatocellular Cancer: What Can We Learn from Epidemiology Comparing Iran and Worldwide Findings?
por: Smolle, Elisabeth, et al.
Publicado: (2012)

What can we learn from Plausible Values?
por: Marsman, Maarten, et al.
Publicado: (2016)

Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?
por: Knoll, Stefanie, et al.
Publicado: (2013)

Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990
por: Standaert, Baudouin
Publicado: (2023)

Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project
por: Van Baarle, Debbie, et al.
Publicado: (2020)

A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer
por: Demarteau, Nadia, et al.
Publicado: (2010)

The cost of vaccination throughout life: A western European overview
por: Ethgen, Olivier, et al.
Publicado: (2016)

What Can We Demonstrate?
por: Mills, G. A.
Publicado: (1896)

Reversal Agents: What We Have and What We Can Expect
por: Ruff, Christian T.
Publicado: (2018)

Enhancer RNA: What we know and what we can achieve
por: Han, Zhenzhen, et al.
Publicado: (2022)

What we can and what we cannot see with extracellular multielectrodes
por: Chintaluri, Chaitanya, et al.
Publicado: (2021)

The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013)

School health in Europe: a review of workforce expenditure across five countries
por: van der Pol, Simon, et al.
Publicado: (2020)

Lessons Learned from Long-Term Assessment of Rotavirus Vaccination in a High-Income Country: The Case of the Rotavirus Vaccine Belgium Impact Study (RotaBIS)
por: Standaert, Baudouin, et al.
Publicado: (2020)

What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries
por: Portnoy, Allison, et al.
Publicado: (2021)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

How we remember what we can do
por: Declerck, Gunnar
Publicado: (2015)

What can we learn from other countries—lessons from the CAJC Happiness Report
por: Roeth, Anjali A.
Publicado: (2019)

Need of cost-effective vaccines in developing countries: What plant biotechnology can offer?
por: Waheed, Mohammad Tahir, et al.
Publicado: (2016)

Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures
por: Ethgen, Olivier, et al.
Publicado: (2015)

2. How is the economic assessment of vaccines performed today?
por: Standaert, Baudouin, et al.
Publicado: (2017)

Towards a more comprehensive approach for a total economic assessment of vaccines?: 1. The building blocks for a health economic assessment of vaccination
por: Standaert, Baudouin, et al.
Publicado: (2017)

What Can We Do to Be Saved?
por: Visanska, Samuel A.
Publicado: (1913)

Antiseizure medications and oral contraceptives: Impact of enzyme inducers on pregnancy outcomes and costs
por: Anderson, Seri, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_13fijh5mqi3p3nfmuf7ravrolo